Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Neurotrophic Keratitis > Restoring key neuropeptides protects against infection after corneal nerve loss
  • Neurotrophic Keratitis

Restoring key neuropeptides protects against infection after corneal nerve loss

Ophthalmology 360

When corneal sensory nerves are damaged, tear production decreases and key protective neuropeptides are reduced, making the eye more susceptible to bacterial infection, according to a study that found replacing these neuropeptides can restore defenses and reduce the risk of infection.

Researchers used a combination of subconjunctival and topical bupivacaine in mice to achieve localized, long-lasting nerve reduction, cutting corneal nerve density by about 50% without damaging the epithelium.

This nerve loss led to a 56% drop in tear production and significant decreases in substance P and calcitonin gene-related peptide (CGRP).  Lower neuropeptide levels were linked to greater bacterial adhesion, including a 20% rise for Pseudomonas aeruginosa and an 18% increase for Staphylococcus aureus.

Researchers noted that replacing substance P or CGRP restored normal neuropeptide levels, and adding CGRP specifically reduced bacterial adhesion. The model could help advance research into conditions like diabetic keratopathy and neurotrophic keratitis, as well as guide strategies for infection prevention and neuroprotective therapies.

Reference
Datta A, Orallo GK, Nelson N. Corneal sensory nerve loss induced by repeated subconjunctival and topical bupivacaine disrupts tear secretion and enhances bacterial adhesion via neuropeptide modulation. PLoS One. 2025;20(8):e0329112. doi: 10.1371/journal.pone.0329112. PMID: 40758689; PMCID: PMC12321116.

Share

Related Content

  • Neurotrophic Keratitis

Shelf-stable amniotic membrane improved outcomes in early-stage neurotrophic keratopathy

  • Conference Roundup

Cryopreserved amniotic membrane significantly improves ocular surface integrity in patients with severe keratoconjunctivitis sicca and neurotrophic keratopathy

  • Conference Roundup

CAM360 with a collagen shield provides rapid epithelial healing with better tolerability and safety than when used with bandage contact lenses

  • Neurotrophic Keratitis

Early detection and targeted treatment strategies are critical for optimal outcomes in neurotrophic keratitis

  • Neurotrophic Keratitis

Amniotic membrane improves severe autoimmune-related KCS and NK outcomes

  • Neurotrophic Keratitis

Systemic abnormalities commonly found in neurotrophic keratopathy patients, study finds

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon